- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-02-0016551

About Glukem Biocare Private Limited
Data last updated:
Glukem Biocare Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 October 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2014PTC096067. Its GSTIN is 36AAFCG7670N2ZY (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5.15 Cr and a paid-up capital of ₹99 Lakh. It is led by directors including Rakesh Chinnala and Varun Vihar Madupaduga.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Module No. 206/A Emd Business Park Nsic E.C.I.L. Post, Hyderabad, Telangana, India – 500062.
As per the financials filed for FY 2025, the company reported a revenue of ₹108.4 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹5.74 Cr (net margin 5.3%) and EBITDA of ₹10.89 Cr (EBITDA margin 10%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 22% over five years.
The company has about 286 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Glukem. As per MCA filings, the company has open charges of ₹2.96 Cr and satisfied charges of ₹13.05 Cr on record. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹81 Lakh; the latest was in September 2015.
Glukem Biocare Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0016551). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website glukembiocare.com.
Company details
Recognitions & Rankings of Glukem Biocare
Contact details
Glukem Biocare Private Limited's registered office is in Hyderabad, Telangana. Its website is glukembiocare.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressModule No. 206/A Emd Business Park Nsic E.C.I.L. Post, Hyderabad, Telangana, India – 500062
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Glukem Biocare Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Glukem Biocare operates one associated brand: Glukem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pellets, micro-pellets, granules, and capsules for pharmaceutical and nutraceutical drugs. | glukembiocare.com |
Business activity
The main business activity of Glukem Biocare is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Glukem Biocare Private Limited, buy the company report.
Financials of Glukem Biocare Private Limited
FY 2025 filings availableGlukem Biocare Private Limited reported revenue of ₹108.4 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 3% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.89 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.74 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10% | ||||
| Net Profit Margin | 5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glukem Biocare Private Limited, buy the company report.
Board of directors of Glukem Biocare Private Limited
Glukem Biocare has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Chinnala Also directs: Glukem Pharma Private Limited, Voyage Pharma Private Limited, Glukem Pharmaceuticals Private Limited and 2 more | Director | 20 Oct 2014 | 12 Years 0 Months | Current |
| Varun Vihar Madupaduga Also directs: Glukem Pharmaceuticals Private Limited, Lorven Lux Realty LLP, Lorven Infraacon LLP and 4 more | Director | 20 Oct 2014 | 12 Years 0 Months | Current |
| Rami Reddy Kolli | Director | 05 May 2015 | 11 Years 6 Months | Current |
| Hazra Susanta Kumar | Director | 20 Oct 2014 | 12 Years 0 Months | Current |
| Ramanaiah Madupaduga | Director | 20 Oct 2014 | 12 Years 0 Months | Current |
| Omkar Reddy Bommu | Director | 05 May 2015 | 11 Years 6 Months | Current |
Auditor
Glukem Biocare Private Limited is audited by Alur & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Alur & Associates | FY 2024 | 010251S |
Shareholding
The shareholding of Glukem Biocare Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Glukem Biocare Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Aug 2025 | 101159967 | Axis Bank Limited | ₹30 Lakh | Open | |
| 07 Feb 2025 | 101065246 | Axis Bank Limited | ₹1 Cr | Open | |
| 25 Jan 2024 | 100860746 | Axis Bank Limited | ₹33 Lakh | Open | |
| 28 Oct 2022 | 100680212 | Axis Bank Limited | ₹94.5 Lakh | Open | |
| 06 Oct 2022 | 100675868 | Hdfc Bank Limited | ₹38.49 Lakh | Open |
To see the full charge records of Glukem Biocare Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Glukem Biocare Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹81 Lakh; the latest was in September 2015.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2015 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
| Jul 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2014 | Funding round | ₹81 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Glukem Biocare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glukem Biocare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Glukem Biocare Private Limited has a workforce of 286 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 286 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Glukem Biocare Private Limited, buy the company report.
GST
Glukem Biocare has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCG7670N2ZY | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Glukem Biocare Private Limited, buy the company report.
Recent activity
Glukem Biocare Private Limited has 8 board changes on record since 2014: 6 appointments and 2 cessations. The latest: Omkar Reddy Bommu ceased to be Additional Director on 30 Sep 2015.
9 earlier events are in the company report.
Frequently asked questions
Glukem Biocare is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 October 2014 (12+ years old) and is registered under CIN U24232TG2014PTC096067.
Glukem Biocare has 6 current directors:
- Rakesh Chinnala - Director
- Varun Vihar Madupaduga - Director
- Rami Reddy Kolli - Director
- Hazra Susanta Kumar - Director
- Ramanaiah Madupaduga - Director
- Omkar Reddy Bommu - Director
The latest financial statements of Glukem Biocare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Glukem Biocare is 36AAFCG7670N2ZY, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Glukem Biocare is U24232TG2014PTC096067. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glukem Biocare was incorporated on 20 October 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Glukem Biocare has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹81 Lakh; the latest was in September 2015.
Omkar Reddy Bommu ceased to be Additional Director on 30 Sep 2015. Rami Reddy Kolli ceased to be Additional Director on 30 Sep 2015. Omkar Reddy Bommu was appointed as Director on 05 May 2015. Glukem Biocare has 8 board changes on record in total.
Yes, Glukem Biocare is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0016551).
Glukem Biocare can be reached through the website glukembiocare.com. Its registered office is in Hyderabad, Telangana, India.

